Skip to main content

previous disabled Page of 258
and
  1. No Access

    Article

    Factors related to accurate clinicians’ prediction of survival: an international multicenter study in East Asia

    Recent guidelines for prognostic evaluation recommend clinicians’ prediction of survival (CPS) for survival prediction in patients with advanced cancer. However, CPS is often inaccurate and optimistic. Studies...

    Yusuke Hiratsuka, Sang-Yeon Suh, Seok Joon Yoon, Sung-Eun Choi in Supportive Care in Cancer (2024)

  2. Article

    Open Access

    Differentiation of glioma and solitary brain metastasis: a multi-parameter magnetic resonance imaging study using histogram analysis

    Differentiation of glioma and solitary brain metastasis (SBM), which requires biopsy or multi-disciplinary diagnosis, remains sophisticated clinically. Histogram analysis of MR diffusion or molecular imaging h...

    Yifei Su, Rui Cheng, **xia Guo, Miaoqi Zhang, Junhao Wang, Hongming Ji in BMC Cancer (2024)

  3. Article

    Open Access

    Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers

    The long-term survival benefit of immune checkpoint inhibitors (ICIs) in neoadjuvant and adjuvant settings is unclear for colorectal cancers (CRC) and gastric cancers (GC) with deficiency of mismatch repair (d...

    Zhenghang Wang, Siyuan Cheng, Yanhong Yao, Shengde Liu in Cancer Immunology, Immunotherapy (2024)

  4. No Access

    Article

    Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women

    In East Asia, the incidence of breast cancer has been increasing rapidly, particularly among premenopausal women. An elevated ratio of estrogen-DNA adducts was linked to a higher risk of breast cancer. The pre...

    Hsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu in Breast Cancer Research and Treatment (2024)

  5. No Access

    Article

    GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma

    Despite significantly improved clinical outcomes in EGFR-mutant lung adenocarcinoma, all patients develop acquired resistance and malignancy on the treatment of EGFR tyrosine kinase inhibitors (EGFR-TKIs). Und...

    Ning-xiang Shen, Ming-yu Luo, Wei-ming Gu, Miaomiao Gong, Hui-min Lei, Ling Bi in Oncogene (2024)

  6. No Access

    Article

    Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan

    Chronic hepatitis C (CHC) increases the risk of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). This nationwide cohort study assessed the effectiveness of viral eradication of CHC.

    Chin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, Chi-Yi Chen in Digestive Diseases and Sciences (2024)

  7. No Access

    Article

    A Case of Asymptomatic Duodenal Foreign Body Perforation

    Cheng Ye, Shaopeng Sun, Xuyan Zeng, Li Xu, Yue Hu in Digestive Diseases and Sciences (2024)

  8. Article

    Open Access

    Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1

    Drug resistance remains a significant challenge in the treatment of pancreatic cancer. The development of drug-resistant cell lines is crucial to understanding the underlying mechanisms of resistance and devel...

    Cheng Yu, Yuanhui Su, **n Miao, Changpeng Chai, Huan Tang, Lu Li, Jianfeng Yi in BMC Cancer (2024)

  9. Article

    Open Access

    Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy

    Endocrine therapy is the most important treatment modality of breast cancer patients whose tumors express the estrogen receptor α (ERα). The androgen receptor (AR) is also expressed in the vast majority (80–90...

    Huanyao Gao, Lixuan Wei, Shreya Indulkar, Thanh Thanh. L. Nguyen in Breast Cancer Research (2024)

  10. Article

    Open Access

    JARID2, a novel regulatory factor, promotes cell proliferation, migration, and invasion in oral squamous cell carcinoma

    Accurate regulation of gene expression is crucial for normal development and function of cells. The prognostic significance and potential carcinogenic mechanisms of the related gene JARID2 in OSCC are not yet ...

    Yuxi Cheng, Zhengzheng Song, **gyi Cheng, Zhangui Tang in BMC Cancer (2024)

  11. Article

    Open Access

    Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation

    Warfarin-related nephropathy (WRN) is defined as acute kidney injury subsequent to excessive anticoagulation with warfarin. Patients with mechanical prosthetic valves require long-term anticoagulant therapy. N...

    Fengbo Xu, Guoqin Wang, Lijun Sun, Hong Cheng in Clinical and Experimental Medicine (2024)

  12. Article

    Open Access

    Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment

    Tumor immunotherapies targeting PD-(L)1 exhibit anti-tumor efficacy in only 10–30% of patients with various cancers. Literature has demonstrated that a “hot tumor” which contains high T lymphocytes in the tumo...

    Chun-Chia Cheng, Jungshan Chang, Ai-Sheng Ho in Cancer Immunology, Immunotherapy (2024)

  13. No Access

    Article

    ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles

    Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with no clinically ideal biomarkers for early diagnosis. The objective of this study was to develop and validate a user-friendly diagnostic tool for...

    Tiandong Li, Guiying Sun, Hua Ye, Caijuan Song, Ya**g Shen in British Journal of Cancer (2024)

  14. Article

    Open Access

    Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Kee** with the Evolving Management Protocols

    Grade 1/2 PanNETs are mostly managed similarly, typically without any adjunct treatment with the belief that their overall metastasis rate is low. In oncology literature, Ki67-index of 10% is increasingly bein...

    Ozgur Can Eren MD, Pelin Bagci MD, Serdar Balci MD in Annals of Surgical Oncology (2024)

  15. Article

    Open Access

    Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation

    Esophageal squamous cell carcinoma (ESCC) is a prevalent tumor in the gastrointestinal tract, but our understanding of the molecular mechanisms underlying ESCC remains incomplete. Existing studies indicate tha...

    Jianmin Gu, Shaoyuan Zhang, Dong Lin, Wenhan Wang, **ke Cheng in Cellular Oncology (2024)

  16. No Access

    Article

    Letter to the editor concerning “Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?”

    An-Li Yu, Cheng-Hsuan Tsai, Mei-Fang Cheng in European Journal of Nuclear Medicine and M… (2024)

  17. Article

    Retraction Note: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin

    Steven M. Hill, Chi Cheng, Lin Yuan, Lulu Mao in Breast Cancer Research and Treatment (2024)

  18. Article

    Open Access

    Correction to: A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600EMutant Metastatic Non-Small Cell Lung Cancer

    Christina Baik, Michael L. Cheng, Martin Dietrich, Jhanelle E. Gray in Advances in Therapy (2024)

  19. Article

    Correction: ASO Visual Abstract: A Novel Classification System of Renal Hilar Tumors for Surgical Guidance: Technique, Outcome, and Safety

    Bo-Han Lin MD, Shao-Hao Chen MD, Zhong-Tian Ruan MD in Annals of Surgical Oncology (2024)

  20. Article

    Correction to: Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer

    Yuan Li, Weili Zhang, Jie Du, **long Hu, Ruixi Hu, Ziyang Zeng in Targeted Oncology (2024)

previous disabled Page of 258